CVS names Joyner as CEO under investor pressure, withdraws profit forecast
By Sriparna Roy and Leroy Leo (Reuters) -CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured the company to improve its stagnant share price. It also withdrew its 2024 forecast and gave an outlook …
CVS names Joyner as CEO under investor pressure, withdraws profit forecast Read More »